About The Conference
Conference Series warmly invites participants from around the world to attend the 16th Global Alzheimer’s Summit, scheduled for November 23-24, 2026, in Paris, France. We cordially welcome researchers, academicians, healthcare professionals, clinicians, industry experts, exhibitors, and students to share their knowledge through oral presentations, poster presentations, and exhibitions.
The conference theme, “Advancing Alzheimer’s Care Through Innovation and Global Collaboration,” highlights the importance of uniting global expertise to improve Alzheimer’s research, diagnosis, treatment, and patient care. The summit aims to promote scientific exchange and encourage discussions on the latest breakthroughs and emerging technologies in neuroscience and Alzheimer’s disease.
Alzheimer’s disease is a progressive neurological disorder that affects memory, thinking, and behavior, significantly impacting millions of individuals and families worldwide. The conference will provide a valuable platform to address current challenges, explore innovative therapeutic approaches, and discuss advancements in early diagnosis, prevention, and caregiving strategies.
The 16th Global Alzheimer’s Summit will feature keynote lectures by renowned experts, interactive sessions, and presentations by young researchers, creating an inspiring environment for learning, networking, and collaboration. The conference program includes diverse scientific tracks designed to cover the latest developments and future directions in Alzheimer’s and neuroscience research.
We believe that our distinguished organizing committee and esteemed speakers are the foundation of this prestigious event, and your participation will further enhance the success of Alzheimer’s 2026.
Sessions And Tracks
Track 1: Alzheimer’s Disease and Brain Health
This track focuses on the latest advancements in understanding Alzheimer’s disease, including its causes, progression, diagnosis, and treatment strategies. Discussions will highlight brain health, cognitive decline, and innovative approaches to improving patient outcomes and quality of life.
Track 2: Anxiety, Depression, and Emotional Well-Being
Mental health challenges such as anxiety and depression often accompany neurological disorders and aging. This session explores emotional well-being, stress management, psychological therapies, and emerging treatment approaches aimed at enhancing mental health and patient support.
Track 3: Child and Adolescent Psychiatry
This track emphasizes the diagnosis, prevention, and treatment of mental health disorders in children and adolescents. Topics include behavioral disorders, developmental conditions, emotional disturbances, and innovative psychiatric interventions for young populations.
Track 4: Clinical Neurology and Neurosurgery
Clinical neurology and neurosurgery continue to evolve through advanced research and medical technologies. This session covers neurological disorders, neurophysiology, neurosurgical procedures, rehabilitation, and innovative approaches in patient care.
Track 5: Dementia and Cognitive Disorders
Dementia affects memory, reasoning, and daily functioning, significantly impacting individuals and caregivers. This track explores dementia subtypes, early diagnosis, caregiving strategies, cognitive therapies, and advancements in dementia management.
Track 6: Mental Health and Neurological Wellness
Mental health is essential to overall well-being and influences emotional, psychological, and social functioning. Discussions will include mood disorders, psychological resilience, psychiatric conditions, and strategies for improving mental wellness across all age groups.
Track 7: Neurodegenerative Disorders
Neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Huntington’s disease involve progressive nerve cell degeneration. This track highlights current research, genetic factors, disease mechanisms, and emerging therapeutic approaches.
Track 8: Neurological Disorders and Brain Function
Neurological disorders can affect the brain, spinal cord, and nervous system, leading to physical and cognitive impairments. Sessions will address neurological diseases, rehabilitation techniques, diagnostic advancements, and patient-centered care.
Track 9: Parkinson’s Disease and Movement Disorders
Parkinson’s disease and related movement disorders impact mobility, coordination, and quality of life. This session explores innovative treatments, disease management strategies, rehabilitation, and advancements in neuroscience research.
Track 10: Psychology and Cognitive Science
Psychology and cognitive science contribute significantly to understanding human behavior, cognition, emotions, and mental processes. This track covers behavioral studies, cognitive therapies, neuropsychology, and advancements in psychological research.
Track 11: Public Awareness and Community Support
Raising awareness about Alzheimer’s disease and neurological disorders promotes early diagnosis, improved care, and stronger support systems. This session focuses on education, advocacy, caregiving resources, and community engagement initiatives.
Track 12: Innovations in Dementia and Alzheimer’s Treatment
Rapid advancements in biotechnology and medical research continue to improve dementia treatment approaches. Topics include new therapeutic drugs, clinical trials, precision medicine, biomarker research, and innovative technologies in patient care.
Track 13: Stroke, Neurocardiology, and Brain Circulation
Stroke and neurocardiology are closely connected to brain and cardiovascular health. This track explores stroke prevention, emergency management, rehabilitation, neurovascular disorders, and the relationship between cardiac and neurological conditions.
Track 14: Physiotherapy and Rehabilitation Sciences
Physiotherapy and rehabilitation play a vital role in improving mobility, independence, and recovery for neurological patients. Discussions will focus on rehabilitation techniques, movement therapies, pain management, and patient-centered rehabilitation programs.
Track 15: Medical Biotechnology and Neuroscience Innovation
Medical biotechnology continues to transform Alzheimer’s and neurological disease research. This session highlights innovations in neuroimaging, biomarker discovery, regenerative medicine, artificial intelligence, and emerging technologies in neuroscience and patient care.
Why to attend?
-
Latest Advancements in Alzheimer’s Research
Explore the newest breakthroughs in Alzheimer’s research, including innovative therapies, advanced diagnostic technologies, and emerging treatment strategies. The 16th Global Alzheimer’s Summit 2026 will provide valuable insights into the future of Alzheimer’s care and neuroscience innovation.
-
Global Networking Opportunities
Connect with internationally recognized neurologists, psychiatrists, researchers, healthcare professionals, academicians, and industry experts. The conference offers an excellent platform to exchange ideas, establish collaborations, and build strong professional networks.
-
Expert-Led Scientific Sessions
Gain knowledge from leading experts and keynote speakers who will present the latest developments in Alzheimer’s disease, neurodegenerative disorders, mental health, and patient care. Sessions will cover both clinical and research perspectives to provide a comprehensive learning experience.
-
Innovations in Patient Care and Treatment
Discover advanced approaches to improving patient outcomes and caregiver support. The summit will showcase innovative healthcare models, rehabilitation techniques, and personalized treatment strategies designed to enhance quality of life.
-
International Perspectives and Collaboration
The conference brings together participants from around the globe, encouraging discussions on worldwide challenges, research developments, and collaborative solutions in Alzheimer’s disease and neurological disorders.
-
Contribute to Future Developments
Participate in meaningful discussions that can influence future research, healthcare policies, and treatment advancements. Your expertise and contributions can help shape the next generation of Alzheimer’s care and scientific innovation.
-
Experience the Beauty of Paris
Held in the vibrant city of Paris, France, the summit also offers an opportunity to experience one of the world’s most iconic destinations, known for its culture, history, architecture, and inspiring atmosphere.
Who can attend
-
Neurologists and Neuroscientists
-
Psychiatrists and Psychologists
-
Alzheimer’s and Dementia Researchers
-
Healthcare Professionals and Clinicians
-
Geriatricians and Elderly Care Specialists
-
Nurses and Caregivers in Dementia Care
-
Academicians, Professors, and Medical Students
-
Pharmaceutical, Biotechnology, and Healthcare Industry Experts